Psychometric properties of the chinese version of the 25-item national eye institute visual function questionnaire

Optometry and Vision Science

Volumn 85, Issue 11, 2008, Pages 1091-1099

  Wang, Chong Wen ^a,b   Chan, Cecilia Lai Wan ^a   Jin, Hui Yu ^b  

^a UNIVERSITY OF HONG KONG   (Hong Kong)

^b HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

Author keywords

NEI VFQ; Psychometric; Questionnaire; Rasch analysis; Visual function

Indexed keywords

OPHTHALMOLOGY; OPTOMETERS;

NEI-VFQ; PSYCHOMETRIC; QUESTIONNAIRE; RASCH ANALYSIS; VISUAL FUNCTIONS;

SURVEYS;

ADULT; AGED; AGING; ARTICLE; CHINA; CHINESE; CONTROLLED STUDY; DISEASE COURSE; DISEASE SEVERITY; EYE CARE; EYE EXAMINATION; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; NATIONAL EYE INSTITUTE VISUAL FUNCTION QUESTIONNAIRE; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PSYCHOMETRY; QUALITY OF LIFE; RASCH ANALYSIS; RELIABILITY; RETINA MACULA AGE RELATED DEGENERATION; SENESCENCE; SHORT FORM 12; VALIDATION PROCESS; VALIDITY; VISION; VISUAL DISORDER; VISUAL IMPAIRMENT; ASIAN; EYE DISEASE; HOSPITALIZATION; LANGUAGE; METHODOLOGY; NATIONAL HEALTH ORGANIZATION; PSYCHOLOGICAL ASPECT; QUESTIONNAIRE; REPRODUCIBILITY; UNITED STATES;

AGED; AGED, 80 AND OVER; ASIAN CONTINENTAL ANCESTRY GROUP; EYE DISEASES; FEMALE; HUMANS; LANGUAGE; MALE; NATIONAL EYE INSTITUTE (U.S.); PSYCHOMETRICS; QUESTIONNAIRES; REPRODUCIBILITY OF RESULTS; SEVERITY OF ILLNESS INDEX; UNITED STATES; VISION, OCULAR;

EID: 59249091184     PISSN: 10405488     EISSN: None     Source Type: Journal    
DOI: 10.1097/OPX.0b013e31818b9f23     Document Type: Article

References (36)

1. Sherwood MB, Garcia-Siekavizza A, Meltzer MI, Hebert A, Burns AF, McGorray S. Glaucoma's impact on quality of life and its relation to clinical indicators. A pilot study. Ophthalmology 1998;105: 561-6.
2. Parrish RK, Gedde SJ, Scott IU, Feuer WJ, Schiffman JC, Mangione CM, Montenegro-Piniella A. Visual function and quality of life among patients with glaucoma. Arch Ophthalmol 1997;115: 1447-55.
3. Mangione CM, Berry S, Spritzer K,Janz NK, Klein R, Owsley C, Lee PP. Identifying the content area for the 51-item National Eye Institute Visual Function Questionnaire: results from focus groups with visually impaired persons. Arch Ophthalmol 1998;116:227-33.
4. Mangione CM, Lee PP, Pitts J, Gutierrez P, Berry S, Hays RD. Psychometric properties of the National Eye Institute Visual Function Questionnaire (NEI-VFQ). NEI-VFQ Field Test Investigators. Arch Ophthalmol 1998;116:1496-504.
5. Patrick DL, Chiang YP. Measurement of health outcomes in treatment effectiveness evaluations: conceptual and methodological challenges. Med Care 2000;38:II14-25.
6. Owen CG, Rudnicka AR, Smeeth L, Evans JR, Wormald RP, Fletcher AE. Is the NEI-VFQ-25 a useful tool in identifying visual impairment in an elderly population? BMC Ophthalmol 2006;6:24.
7. Mangione CM, Lee PP, Gutierrez PR, Spritzer K, Berry S, Hays RD. Development of the 25-item National Eye Institute Visual Function Questionnaire. Arch Ophthalmol 2001;119:1050-8.
8. Broman AT, Munoz B, West SK, Rodriguez J, Sanchez R, Snyder R, Klein R. Psychometric properties of the 25-item NEI-VFQ in a His- panic population: Proyecto VER. Invest Ophthalmol Vis Sci 2001; 42:606-13.
9. Globe D, Varma R, Azen SP, Paz S, Yu E, Preston-Martin S. Psychometric performance of the NEI VFQ-25 in visually normal Latinos: the Los Angeles Latino Eye Study. Invest Ophthalmol Vis Sci 2003; 44:1470-8.
10. Rossi GC, Milano G, Tinelli C. The Italian version of the 25-item National Eye Institute Visual Function Questionnaire: translation, validity, and reliability. J Glaucoma 2003;12:213-20.
11. Nordmann JP, Viala M, Sullivan K, Arnould B, Berdeaux G. Psychometric validation of the National Eye Institute Visual Function Questionnaire-25 (NEI VFQ-25) French version: in a population of patients treated for ocular hypertension and glaucoma. Pharmacoeconomics 2004;22:197-206.
12. Toprak AB, Eser E, Guler C, Baser FE, Mayali H. Cross-validation of the Turkish version of the 25-item National Eye Institute Visual Functioning Questionnaire (NEI-VFQ 25). Ophthalmic Epidemiol 2005;12:259-69.
13. Suzukamo Y, Oshika T, Yuzawa M, Tokuda Y, Tomidokoro A, Oki K, Mangione CM, Green J, Fukuhara S. Psychometric properties of the 25-item National Eye Institute Visual Function Questionnaire (NEI VFQ-25), Japanese version. Health Qual Life Outcomes 2005; 3:65.
14. Chakravarthy U, Stevenson M. Self-reported visual functioning and quality of life in age-related macular degeneration. Curr Opin Oph-thalmol 2005;16:179-83.
15. Ware J Jr, Kosinski M, Keller SD. A 12-Item Short-Form Health Survey: construction of scales and preliminary tests of reliability and validity. Med Care 1996;34:220-33.
16. Lam CL, Tse EY, Gandek B. Is the standard SF-12 health survey valid and equivalent for a Chinese population? Qual Life Res 2005;14: 539-47.
17. Ware JE Jr, Sherbourne CD. The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection. Med Care 1992;30:473-83.
18. McHorney CA, Ware JE Jr, Raczek AE. The MOS 36-Item Short-Form Health Survey (SF-36): II. Psychometric and clinical tests of validity in measuring physical and mental health constructs. Med Care 1993;31:247-63.
19. Li L, Wang H, Shen Y. Development and psychometric tests of a Chinese version of the SF-36 Health survey scales. Zhonghua Yu Fang Yi Xue Za Zhi 2002;36:109-13.
20. Shrout PE. Measurement reliability and agreement in psychiatry. Stat Methods Med Res 1998;7:301-17.
21. Rubin GS, West SK, Munoz B, Bandeen-Roche K, Zeger S, Schein O, Fried LP. A comprehensive assessment of visual impairment in a population of older Americans. The SEE Study. Salisbury Eye Evaluation Project. Invest Ophthalmol Vis Sci 1997;38:557-68.
22. Walter SD, Eliasziw M, Donner A. Sample size and optimal designs for reliability studies. Stat Med 1998;17:101-10.
23. Streiner DL, Norman GR. Health Measurement Scales: A Practical Guide to Their Development and Use, 3rd ed. New York: Oxford University Press; 2003.
24. Chassany O, Sagnier P, Marquis P, Fullerton S, Aaronson N. Patient-reported outcomes: the example of health-related quality of life - a European guidance document for the improved integration of health-related quality of life assessment in the drug regulatory process. Drug Inf J 2002;36:209-38.
25. Cunningham WE, Hays RD, Burton TM, Kington RS. Health status measurement performance and health status differences by age, ethnicity, and gender: assessment in the medical outcomes study. J Health Care Poor Underserved 2000;11:58-76.
26. Stelmack JA, Stelmack TR, Massof RW. Measuring low-vision reha- bilitation outcomes with the NEI VFQ-25. Invest Ophthalmol Vis Sci 2002;43:2859-68.
27. Smith RM. The distributional properties of Rasch item fit statistics. Educ Psychol Meas 1991;51:541-65.
28. Bond TG, Fox CM. Applying the Rasch Model: Fundamental Measurement in the Human Sciences. Mahwah, NJ: L. Erlbaum; 2001.
29. Massof RW. Likert and Guttman scaling of visual function rating scale questionnaires. Ophthalmic Epidemiol 2004;11:381-99.
30. Massof RW. Application of stochastic measurement models to visual function rating scale questionnaires. Ophthalmic Epidemiol 2005; 12:103-24.
31. Massof RW, Fletcher DC. Evaluation of the NEI visual functioning questionnaire as an interval measure of visual ability in low vision. Vision Res 2001;41:397-413.
32. Hays RD, Anderson RT, Revicki D Assessing reliability and validity of measurement in clinical trials. In: Staquet M, Hay R, Fayers P, eds. Quality of Life Assessment in Clinical Trials: Methods and Practice. Oxford: Oxford University; 1998:169-82.
33. Hutchinson JF Quality of life in ethnic groups. In: Spilker B, ed. Quality of Life and Pharmacoeconomics in Clinical Trials, 2nd ed. Philadelphia: Lippincott-Raven; 1996:587-93.
34. McDowell I, Newell C. Measuring Health: A Guide to Rating Scales and Questionnaires, 2nd ed. New York: Oxford University Press; 1996.
35. PesudovsK. Patient-centred measurementin ophthalmology - a paradigm shift. BMC Ophthalmol 2006;6:25.
36. Massof RW. An interval-scaled scoring algorithm for visual function questionnaires. Optom Vis Sci 2007;84:689-704.